The Unified Patent Court’s approach to interim injunctions will influence businesses’ patent strategies in Europe, say experts – OUT-LAW.com

‘The ease with which businesses will be able to win interim injunctions to defend against rivals’ infringements of their patents will be influential in determining whether companies engage with the new Unified Patent Court (UPC).’

Full story

OUT-LAW.com, 22nd February 2016

Source: www.out-law.com

Implementing the Unitary Patent in the UK – NIPC Law

Posted February 22nd, 2016 in consultations, EC law, intellectual property, news, patents by sally

‘Whatever happens on 23 June 2016 HMG will have to make rules to implement the Agreement on a Unified Patent Court in the United Kingdom. The reason I say that is that the Agreement comes into force after 13 countries, including France, Germany and the UK, ratify the Agreement. Nine countries including France have already done so (see the European Council’s website). Parliament has enacted primary legislation to enable the Secretary of State to give effect to the Agreement in the UK by order in council (see S,17 of the Intellectual Property Act 2014 inserting a new s.88A and s.88B into the Patents Act 1977). As it would take time to negotiate an exit agreement under art 50 (2) of the Treaty on European Union the Agreement will almost certainly come into force while the UK is still an EU member. There would have to be some sort of secondary legislation at least for the time in which the UK remains a party to the UPC Agreement.’

Full story

NIPC Law, 22nd February 2016

Source: www.nipclaw.blogspot.co.uk

UK to push ahead with reforms to rules on unjustified threats on intellectual property rights – OUT-LAW.com

Posted February 1st, 2016 in consultations, copyright, intellectual property, news, patents, trade marks by tracey

‘The UK government is to legislate to bring greater consistency to laws concerning the communications intellectual property (IP) rights holders send to alleged infringers of their rights.’

Full story

OUT-LAW.com, 1st February 2016

Source: www.out-law.com

UK legislates to support ratification of Unified Patent Court reforms – OUT-LAW.com

Posted January 22nd, 2016 in courts, EC law, news, patents, regulations by sally

‘The UK government has prepared legislation to give effect to EU legislation on the unitary patent and to the Agreement on the Unified Patent Court (UPC), which backs the creation of a new UPC for resolving disputes over new unitary patents.’

Full story

OUT-LAW.com, 21st January 2016

Source: www.out-law.com

Innovative start-ups and the importance of getting the paperwork right – Technology Law Update

Posted January 15th, 2016 in assignment, contracts, law firms, negligence, news, patents by sally

‘A dispute over an unsuccessful start-up turns messy, but clears up a point of confusion over patent assignments.’

Full story

Technology Law Update, 14th January 2016

Source: www.technology-law-blog.co.uk

The Importance of Keeping Promises: Warner-Lambert Company LLC v Sandoz GmbH and Others – NIPC Law

Posted December 15th, 2015 in appeals, medicines, news, patents, restraining orders by sally

‘In Swiss Style Claims: Warner-Lambert Companv Actavis 25 Jan 2015 I explained that Warner-Lambert LLC had a patent for a drug called pregabalin for treating epilepsy and GAD (generalized anxiety disorder). That patent expired in 2013 although the monopoly was extended for a short time by a supplementary protection certificate which has now lapsed. Warner-Lambert discovered a new use for pregabalin in the treatment of neuropathic pain for which it was granted a new patent. Actavis sought the revocation of the new patent on grounds of obviousness and insufficiency and applied for permission to market pregabalin for the treatment of epilepsy and GAD. The case that I discussed in my case note was an unsuccessful attempt by Warner-Lambert to impose conditions on the sale of pregabilin in the UK (see Warner -Lambert Company, LLC v Actavis Group Ptc EHF and others [2015] EWHC 72 (Pat)).’

Full story

NIPC Law, 9th December 2015

Source: www.nipclaw.blogspot.co.uk

Practice Statement: Listing of Cases for Trial in the Patents Court – Courts and Tribunals Judiciary

Posted December 11th, 2015 in lists, news, patents, practice directions by tracey

‘The Patents Court endeavours bring patent cases on for trial where possible within 12 months of the claim being issued. To this end, the following procedure will be adopted.’

Full statement

Courts and Tribunals Judiciary, 10th December 2015

Source: www.judiciary.gov.uk

Prior disclosures do not undermine patent filings made on the same day, rules High Court – OUT-LAW.com

Posted December 2nd, 2015 in disclosure, news, patents, time limits by sally

‘Disclosure of information relevant to an invention does not mean the invention cannot be patented as long as the patent application is filed later the same day, the High Court has ruled.’

Full story

OUT-LAW.com, 1st December 2015

Source: www.out-law.com

Civil Restraint Orders in IPEC: Perry v Brundle – NIPC Law

‘This case note discusses the power of a judge of the Intellectual Property Enterprise Court to make an extended civil restraint order under para 3.2 (1) (b).’

Full story

NIPC Law, 12th Ocotber 2015

Source: www.nipclaw.blogspot.co.uk

The Pregabalin Trial: Generics (UK) Ltd v Warner-Lambert Company LLC – NIPC Law

Posted September 22nd, 2015 in injunctions, medicines, news, patents by sally

‘According to drugs.com, pregabalin is an anti-epileptic drug which works by slowing down impulses in the brain that cause seizures. A European patent for the drug was granted to Warner-Lambert Co, LLC (“Warner-Lambert”)(now a subsidiary of Pfizer Inc.) under EP number 0 641 330. That patent expired on 17 May 2013 but was extended by a supplementary protection certificate (“SPC”) until 17 May 2018. That SPC was allowed to lapse on 14 Oct 2013 and Warner-Lambert’s data exclusivity in respect of the data used to obtain the marketing authorisation for prehabalin expired on 8 July 2014. Since then anybody has been free to make, import or sell pregabalin for treating epilepsy and generalized anxiety disorder in the United Kingdom and several companies including some of the parties to these proceedings have done just that.’

Full story

NIPC Law, 18th September 2015

Source: www.nipclaw.blogspot.co.uk

Salt in the wound. How precise words in patent claims can be misleading – Technology Law Update

Posted July 3rd, 2015 in medicines, news, patents by tracey

‘Patents are powerful tools, but they only bite on the materials or methods described in their claims. Or do they? Two recent appeal decisions show that the monopoly owned by a patent-holder can spill out over the edges of the claims, making life uncertain for those trying to steer a way around them.’

Full story

Technology Law Update, 3rd July 2015

Source: www.technology-law-blog.co.uk

Court of Appeal clarifies the scope of numerical ranges in patent claims – OUT-LAW.com

Posted June 26th, 2015 in interpretation, news, patents by sally

‘The way numerical ranges used to limit the scope of a patent claim should be interpreted has been clarified by the Court of Appeal in London.’

Full story

OUT-LAW.com, 25th June 2015

Source: www.out-law.com

Dispelling myths about EU law – OUP Blog

Posted June 17th, 2015 in copyright, EC law, intellectual property, news, patents by sally

‘What are the most common myths surrounding the laws of the European Union? We asked two experts, Phil Syrpis and Catherine Seville, to describe and combat some misconceptions. From the Maastricht Treaty to intellectual property law, here are some of the topics they addressed.’

Full story

OUP Blog, 17th June 2015

Source: www.blog.oup.com

Wrapped up: Everseal Stationery Products Ltd v Document Management Solutions Ltd – NIPC Law

Posted May 6th, 2015 in intellectual property, news, patents by sally

‘Not all patented inventions are high tech. The title of the patent in Everseal Stationery Products Ltd v Document Management Solutions Ltd. and Others [2015] EWHC 842 (IPEC) (1 April 2015) was “Mailer with self-adhesive closure”.’

Full story

NIPC Law, 5th May 2015

Source: www.nipclaw.blogspot.co.uk

Jeremy Phillips talks to Law Vox – OUP Law Vox

Posted March 25th, 2015 in copyright, human rights, intellectual property, news, patents by sally

‘George Miller introduces leading experts from a wide variety of disciplines to discuss significant aspects of their respective fields in a series of accessible and stimulating discourses.George Miller introduces leading experts from a wide variety of disciplines to discuss significant aspects of their respective fields in a series of accessible and stimulating discourses.

Jeremy Phillips – Intellectual Property Consultant, Olswang, London; Professorial Fellow at the Queen Mary Intellectual Property Research Institute. Editor of Journal of Intellectual Property Law & Practice
An Honorary Research Fellow of the Intellectual Property Institute and Professorial Fellow, Queen Mary Intellectual Property Research Institute, Professor Phillips has held positions in several leading academic institutions. He is the founder editor of the Journal of Intellectual Property Law & Practice and is also blogmeister of the IPKat and other weblogs.

In this podcast Jeremy outlines the field of IP law and how it was seen at the start of his intellectual property law career. Jeremy discusses how intellectual property evolved and grew to encompass many different features. He talks about how intellectual property interacts with the commercial world, including copyright in books and patents in pharmaceuticals, and how intellectual property law works in tandem with human rights law, and he also describes how the practical application of intellectual property works, and how human behaviour influences this.’

Listen

OUP Law Vox, 22nd March 2015

Source: www.soundcloud.com/oupacademic

Source:

Patents: the Difficulties of Designing Around a Patent: Adaptive Spectrum and Signal Alignment Inc v British Telecommunications Plc #2 – NIPC Law

Posted January 13th, 2015 in news, patents, telecommunications by sally

‘In Adaptive Spectrum and Signal Alignment Inc v British Telecommunications Plc [2013] EWHC 3768 (Pat) (3 Dec 2013) the claimant sued the defendant telecommunications company for infringing two of its European patents:

EP 2,259,495 adaptive DSL margin and band control using historical operational data (“495”); and
EP 1,869,790 DSL state and line profile control (“790”).’

Full story

NIPC Law, 12th January 2015

Source: www.nipclaw.blogspot.co.uk

Time for a fry-up – patent claims reinterpreted in Jarden v SEB – Technology Law Update

Posted January 9th, 2015 in appeals, food, news, patents by sally

‘In a surprise end-of-year appeal success Jarden has escaped the heat of SEB’s ‘dry fryer’ patent. The apparatus claimed by the patent allows a user to produce crispy chips without needing a pan full of hot fat.’

Full story

Technology Law Update, 8th January 2015

Source: www.technology-law-blog.co.uk

Further appeal against European Commission ‘pay for delay’ patent settlement decision – Zenith Chambers

Posted January 6th, 2015 in appeals, delay, EC law, medicines, news, patents by sally

‘The European Commission’s controversial infringement decision relating to ‘pay for delay’ pharmaceutical patent settlements is subject to a further challenge.’

Full story

Zenith Chambers, 23rd December 2014

Source: www.zenithchambers.co.uk

Patents: Court of Appeal allows the appeal in Jarden – NIPC Law

Posted January 6th, 2015 in appeals, intellectual property, news, patents by sally

‘In Jarden Consumer Solutions (Europe) Ltd v SEB SA and Another [2014] EWHC 445 (Pat) (28 Feb 2014) Jarden Consumer Solutions (Europe) Ltd (“Jarden”) sued SEB SA (“SEB”) for the revocation of its European patent number 2.085,003 (“the patent”) for deep fryer with automatic fat coating. SEB counterclaimed for infringement of the patent by importing and selling the Breville Halo Health fryer. The action came on for trial before Mr Justice Arnold who found that 3 of the claims of the patent were invalid but 3 others were valid and had been infringed. Jarden appealed against the judge’s construction of the patent and his finding of infringement. The appeal was heard by Lord Justices Vos and Burnett and Sir Timothy Lloyd in Jarden Consumer Solutions (Europe) Ltd v SEB SA and Another [2014] EWCA Civ 1629 (17 Dec 2014).’

Full story

NIPC Law, 1st January 2015

Source: www.nipclaw.blogspot.co.uk

‘Selection’ patents invalid unless they make ‘plausible’ technical contribution, rules High Court – OUT-LAW.com

Posted December 8th, 2014 in medicines, news, patents by sally

‘Pharmaceutical companies stand to lose patent monopolies that cover a number of individual compounds within a broader chemical formula if they cannot show a plausible link between the compounds covered by the patent and a technical contribution to treatment claimed in the patent, the High Court has confirmed.’

Full story

OUT-LAW.com, 4th December 2014

Source: www.out-law.com